These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8388880)

  • 1. Altered hypothalamic-pituitary-adrenal axis responsiveness in myotonic dystrophy: in vivo evidence for abnormal dihydropyridine-insensitive calcium transport.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1433-8. PubMed ID: 8388880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
    Buyalos RP; Jackson RV; Grice GI; Hockings GI; Torpy DJ; Fox LM; Boots LR; Azziz R
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3219-24. PubMed ID: 9745431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormone.
    Hockings GI; Grice JE; Walters MM; Crosbie GV; Torpy DJ; Jackson RV
    Neuroendocrinology; 1995 Feb; 61(2):198-206. PubMed ID: 7753339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophy.
    Grice JE; Jackson RV; Hockings GI; Torpy DJ; Walters MM; Crosbie GV
    J Clin Endocrinol Metab; 1995 Jan; 80(1):179-84. PubMed ID: 7829609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical inhibition by aspirin of naloxone-induced adrenocorticotropin secretion in myotonic dystrophy.
    Hockings GI; Jackson RV; Grice JE; Crosbie GV; Walters MM; Torpy DJ; Jackson AJ
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1424-7. PubMed ID: 8200945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ; Jackson RV; Grice JE; Hockings GI; Crosbie GV; Walters MM
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):157-61. PubMed ID: 8039271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-type calcium channels and CRH-mediated ACTH and cortisol release in humans.
    Hockings GI; Grice JE; Walters MM; Jackson RV
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):303-7. PubMed ID: 1648460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRH-mediated pituitary-adrenal responses are inhibited by nifedipine in humans.
    Grice JE; Hockings GI; Jackson AJ; Jackson RV
    Neuroreport; 1992 Apr; 3(4):373-6. PubMed ID: 1325203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin inhibits vasopressin-induced hypothalamic-pituitary-adrenal activity in normal humans.
    Nye EJ; Hockings GI; Grice JE; Torpy DJ; Walters MM; Crosbie GV; Wagenaar M; Cooper M; Jackson RV
    J Clin Endocrinol Metab; 1997 Mar; 82(3):812-7. PubMed ID: 9062488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
    Inder WJ; Hellemans J; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    J Clin Endocrinol Metab; 1995 Jan; 80(1):244-8. PubMed ID: 7829620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.